When many families plan for parenthood today, uterine fibroids have become one of the most common concerns for intended parents considering Mexico surrogacy. Especially for women over 35, discovering fibroids during a medical checkup can create anxiety about both personal health and the potential impact on the surrogacy process and the baby’s development. At the same time, fertility medications used during assisted reproduction often raise questions such as whether they may worsen fibroids or affect the baby. Understanding the scientific facts behind these concerns can help intended parents evaluate their situation more rationally and prepare more confidently for Mexico surrogacy.
How Uterine Fibroids May Affect Surrogacy
Uterine fibroids are common benign tumors in women of reproductive age, usually located within the uterine muscle layer or beneath the uterine lining. Small, asymptomatic fibroids generally do not significantly affect pregnancy, but fibroids with certain locations or larger sizes may interfere with embryo implantation, increase miscarriage risk, or contribute to abnormal fetal positioning. In the Mexico surrogacy process, since the embryos are provided by the intended parents, the surrogate mother mainly carries the pregnancy.
Can Fertility Medications Make Fibroids Worse?
Fertility medications primarily act on the ovaries to stimulate follicle development and egg maturation. While fibroids are somewhat hormone-dependent, short-term and medically supervised stimulation generally does not cause significant fibroid growth. In clinical practice, doctors select gentle and personalized stimulation protocols based on hormone levels and fibroid conditions in order to minimize potential uterine stimulation. The stimulation cycle usually lasts 10–14 days, and once the eggs are retrieved, the medications are quickly metabolized without long-term retention in the body. For women with a history of fibroids, medical teams provide closer monitoring and may combine additional supportive approaches when necessary to ensure safety throughout the stimulation process. Extensive research has shown that properly managed stimulation does not significantly increase the risk of fibroid malignancy, though individualized evaluation remains essential.
Comprehensive Risk Management in Mexico Surrogacy
Mexico surrogacy emphasizes full medical supervision throughout the process. After embryos are created by the intended parents, surrogate mothers undergo strict pre-pregnancy screening, including fibroid assessment and uterine evaluation. If fibroids do not interfere with pregnancy, single embryo transfer remains the standard recommendation to reduce complications associated with multiple pregnancies. The full cycle typically takes 12–18 months, with the primary focus placed on embryo quality optimization and careful surrogate matching.
Intended parents can remain involved throughout the process, from egg retrieval and embryo culture to transfer and pregnancy monitoring, allowing them to follow progress in real time. This transparent approach helps identify and address potential issues early, making the surrogacy journey more reassuring. Intended parents considering surrogacy are encouraged to complete thorough preparation in advance, including detailed gynecological examinations, hormone evaluations, and genetic counseling. Maintaining healthy lifestyle habits, weight management, and regular sleep patterns can also help improve overall reproductive health.
POWER FERTILITY CENTER provides a professional support platform for families seeking reproductive solutions. Located in the center of Mexico City, Power Fertility Clinic is a fully licensed fertility center operated by a U.S. reproductive medical organization and located just 500 meters from the U.S. Embassy, following FDA standards. Power IVF offers comprehensive services ranging from egg and sperm donation to third-party reproduction, covering the full process of U.S. egg freezing and U.S. IVF. The clinic is equipped with advanced technology and an experienced medical team specializing in IVF-PGT (PGT-A), helping families pursue healthier pregnancies and births. Mexican law allows gender selection and the import of frozen reproductive tissues including sperm, eggs, and embryos, and is open to all individuals, including single parents and LGBTQ families. Power IVF is licensed to receive frozen samples from overseas, ensuring a safe and efficient fertility journey.
